| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $123K | — |
| SG&A Expense | $853 | -92.6% |
| Pre-tax Income | -$342K | -332.4% |
| Net Income | -$342K | -332.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2K | +38.3% |
| Current Assets | $2K | +38.3% |
| Total Assets | $50K | +4140.9% |
| Current Liabilities | $171K | +0.5% |
| Total Liabilities | $171K | +0.5% |
| Stockholders' Equity | -$121K | +28.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$235K | -240.7% |
| Investing Cash Flow | -$48K | — |
| Financing Cash Flow | $284K | +319.1% |